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R527gene flow, but also raises the question
how and perhaps why this genetic
architecture evolved in the first place.
Additional experiments can be
designed to address the open question
of whether each observed trait
difference is really adaptive, or whether
drift or hitchhiking may have influenced
the evolution of this pollination
syndrome (e.g. [12]). While
maintenance in nature suggests the
observed pollination syndromes are
adaptive [13], it will be exciting to see
additional experiments that specifically
quantify the relative fitness of the
various possible recombinant
genotypes. With this P. exserta x
P. axillaris system, in which tight
linkage rather than an inversion
conditions trait co-segregation, it is
actually possible to construct
recombinant lines to study different
combinations of these traits on
pollinator behavior (e.g. [14]). A
complementary approach could
focus on identification of the causal
variants underlying each trait and
analyzing the genes for molecular
genetic signatures of selection and
linkage disequilibrium across this
super-gene locus (e.g. [5]).
An important question that arises is
how this genetic juxtaposition evolved
in the first place. To glimpse the
evolutionary history of this
arrangement, the authors examined the
chromosomal location of their genetic
markers in related Solanaceae with
sequenced genomes, tomato and
potato. They found that the genes
are spread across multiple
chromosomes in these species,
suggesting that the Petunia
arrangement arose after the divergence
from the potato/tomato lineage [6].
Further investigations are needed
to understand when this occurred
and whether rearrangements were
positively selected specifically
because they brought allelic variants
of these loci together.
What role (if any) do the loci that
differentiate P. exserta and P. axillaris
play in variation in the rest of the
genus? Petunia is composed of
11 species exhibiting three distinct
pollination syndromes – bee,
hummingbird, and hawkmoth [8].
Most species are bee pollinated, with
wide, purple, unscented flowers,
suggesting this is the ancestral state in
Petunia, whereas hummingbird and
hawkmoth pollination are each
represented by only P. exserta andP. axillaris, respectively [8]. Did the tight
chromosomal arrangement of the
causal genes facilitate speciation in
this group, or allow the spread of
pre-packaged versions of complex
phenotypes (e.g. [5])?
The work with P. axillaris and
P. exserta adds an interesting
example to the list of multigenic traits
that can segregate as Mendelian
parcels and provides a mechanism for
how a floral pollination syndromemight
remain intact effectively as a single
trait. This system provides a good
springboard for better understanding
how alternative alleles of multigenic
super genes arise and what role they
may subsequently play in speciation or
the maintenance of phenotypic
variation.
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Immune Surveillance to Restrain
Liver CancerThe p53 tumor suppressor governs multiple cell-intrinsic programs, including
cell-cycle arrest and apoptosis, to curb neoplastic growth. A new study reveals
that p53 also acts through a novel non-cell-autonomous mechanism, by
stimulating the innate immune system to maintain tissue homeostasis and
suppress tumorigenesis.Nitin Raj1 and Laura D. Attardi1,2,*
Inactivation of the p53 tumor
suppressor gene is one of the most
frequent alterations in human cancers,
and p53 deficiency causes a fullypenetrant cancer predisposition in
mice, together underscoring the
crucial role for p53 in tumor
suppression [1,2]. p53 is a
cellular stress sensor that
can restrain neoplastic growth in a
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Figure 1. p53 promotes senescence in hepatic stellate cells to maintain organ integrity and suppress cancer upon liver damage.
In response to liver damage, triggered by conditions such as viral hepatitis, alcohol abuse, and fatty liver disease, hepatic stellate cells (HSCs)
become activated, proliferating and secreting extracellular matrix (ECM) components, leading to fibrosis. In the presence of p53 (bottom), HSCs
undergo senescence, associated with the induction of the senescence-associated secretory phenotype (SASP). Secreted factors include those
that regulate the extracellular matrix (ECM) and those that stimulate immune surveillance by polarizing macrophages to an anti-tumorigenic M1
phenotype and activating natural killer (NK) cells. Together, these responses inhibit cancer, trigger senescent cell clearance, and promote the
resolution of fibrosis. In the absence of p53 activity (top), HSCs continue to proliferate and secrete ECM components, resulting in excessive
fibrosis, cirrhosis, liver failure, and mortality. In addition, p53-deficient HSCs secrete factors that polarize macrophages to a pro-tumorigenic
M2 fate, thereby promoting liver cancer.
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R528cell-autonomous manner by inducing
cell-cycle arrest or apoptosis, or by
regulating metabolism, in response to
stress signals [1–3]. p53 can also inhibit
nascent tumor growth through cellular
senescence, a permanent cell-cycle
arrest response [1,4]. Cellular
senescence is accompanied by a
host of gene expression changes,
including a program known as the
senescence-associated secretory
phenotype (SASP), in which numerous
cytokines and chemokines secreted
from senescent cells promote
communication with cells in the
microenvironment [5,6]. The pivotal
role for p53 in senescence has thus
suggested that p53 may exert some
of its biological effects by stimulating
interplay between cells of the local
milieu. Indeed, such a function for p53
was previously illuminated by studies
showing that p53 can promote tissue
homeostasis after liver damage by
inducing senescence and the SASP
in hepatic stellate cells (HSCs), which
in turn provokes the recruitment
of natural killer (NK) immune cells,
clearance of senescent cells, and
resolution of fibrotic lesions [7].
While highlighting a role for p53 as a‘guardian of the tissue’, what remained
unclear was whether this p53
function contributes to suppressing
tumorigenesis — an important
question, given conflicting reports
that the SASP could both promote
and inhibit tumorigenesis [5,8].
In a recent manuscript published in
Cell, Lujambio et al. [9] have now
investigated how the p53-triggered
SASP in HSCs affects carcinogenesis
in the liver (Figure 1). Wild-type mice
and mice with conditional deletion of
p53 in HSCs (HSC-p53D/D) were treated
with the fibrosis-inducer carbon
tetrachloride (CCl4) to cause chronic
liver damage. The HSC-p53D/D animals
displayed increased liver cirrhosis,
liver failure, and mortality relative to
wild-type controls, underscoring a
key role for p53 in preserving organ
integrity. In addition, the HSC-p53D/D
mice also developed small tumors on
the surface of the liver, often of
wild-type p53 status, suggesting
that p53 inactivation in HSCs might
promote tumorigenesis in other cells.
To solidify the notion that p53 action
in the HSCs promotes a restrictive
environment for tumorigenesis in the
liver, the authors treated mice with thecarcinogen diethylnitrosamine, which
induces hepatocellular carcinoma, and
then examined whether CCl4-induced
fibrosis could enhance the
development of hepatocellular
carcinoma. Indeed, HSC-p53D/D mice
developed more tumors than wild-type
controls. Importantly, all of the tumors
analyzed retained intact p53 genes,
suggesting again that they did not arise
from the p53-null HSC compartment.
These striking findings reveal that p53
acts in a non-cell-autonomous manner
to suppress tumor development.
What is the mechanism by which p53
in HSCs suppresses tumorigenesis in
neighboring cells? To address this
question, the investigators performed
transcriptional profiling and functional
annotation clustering, comparing
senescent HSCs with proliferating
ones, and these experiments revealed
an enrichment for immune response,
NF-kB activation, and protein secretion
signatures in senescent HSCs. By
defining factors preferentially secreted
from senescent HSCs, the
investigators identified interferon g
(IFNg) and interleukin 6 (IL-6), cytokines
that stimulate macrophage activation,
a notable observation given that
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R529macrophages are known to modulate
liver fibrosis [10]. In elegant
experiments to define the effects of
the p53-driven SASP program on
macrophages, the investigators
co-cultured macrophages with
conditioned media from either
proliferating p53-null or senescent
p53-positive HSCs. They discovered
that proliferating p53-deficient
HSCs secrete factors that
polarize macrophages towards a
pro-tumorigenic M2 phenotype, while
factors secreted by p53-expressing
senescent HSCs induce an M1
phenotype, which is associated with
antitumor activity. Macrophages
polarized to an M1 phenotype were in
turn able to eliminate the senescent
HSCs but not the proliferating HSCs
upon co-culture, suggesting that
the p53-induced SASP signals
macrophages to trigger HSC clearance
along with the resolution of fibrosis.
Additionally, the M2-polarized, but not
M1-polarized, macrophages enhanced
the proliferation of premalignant
hepatoblasts, suggesting that
p53-deficient proliferating HSCs
induce a pro-proliferative
microenvironment. Consistent with
previous observations that p53 and
NF-kB cooperate to induce
senescence and the SASP, NF-kB
was required for this p53 SASP
response in HSCs, as attenuation of
NF-kB, or of its transcriptional targets
Il6, Ifn, and Icam, blocked the cytotoxic
effects of macrophages on senescent
HSCs. Based on these collective
observations, the authors conclude
that p53 activity in HSCs promotes
an antitumor microenvironment by
inducing a SASP that stimulates
tumor-combating M1 macrophages,
while keeping tumor-promoting M2
macrophages in check.
This study shows a clear
non-cell-autonomous role for p53 in
tumor suppression in vivo, in keeping
with observations made previously by
Campisi and colleagues when they
originally described the SASP [6]. In
that study, they showed that the
SASP generated by senescent
human cells can promote certain
malignant phenotypes in cultured
cells — epithelial-to-mesenchymal
transition and invasiveness — and that
both the SASP response and these
malignant phenotypes are greatly
exacerbated by p53 inhibition. These
observations indicate that p53 normally
acts to restrain the SASP andassociated pro-tumorigenic activities.
This quantitative augmentation of the
SASP response in the absence of p53 is
in striking contrast with the results
presented here, where a clear switch in
cytokine profiles ensues from p53 loss,
resulting in differential immune cell
activation. Thus, depending on the
setting, the SASP can promote either
anti-proliferative or pro-tumorigenic
phenotypes, and p53 can differentially
modulate the SASP, emphasizing the
importance of investigating such
responses in each particular context
of interest.
The notion that p53 can promote a
dialogue between neighboring cells
recalls a previous study showing that
during prostate cancer development
in mice, p53 activation in epithelial
tumor cells promotes a non-cell-
autonomous, p53-dependent
proliferative arrest in tumor-supportive
stromal fibroblasts [11]. Interestingly,
as the tumors progressed, the
stromal fibroblast growth arrest was
overcome by the selection of
fibroblasts that had inactivated p53 by
genetic mutation. This observation
raised the intriguing possibility that
p53-induced paracrine signals
emanating from one cell may impose
a selection pressure for p53 mutation
in other cells within the
microenvironment, which
could ultimately further fuel tumor
development. These findings suggest
that cells may have evolved strategies
to use p53 both to generate and
to sense non-cell-autonomous
tumor-suppressive signals.
The non-cell-autonomous role of
p53 may have evolved to support the
natural wound-healing process in
damaged tissues. Perhaps the primary
function of the p53-induced SASP in
the liver is to maintain the senescent
state as a means of shutting down
fibrosis-causing HSC proliferation.
Additionally, this response would
fulfill the immediate need to halt the
proliferation of potentially tumorigenic
cells. However, since this response is
only cytostatic in nature and allows the
persistence of damaged cells in the
milieu, a second step involving the
recruitment of the innate immune
system may have evolved to
orchestrate the elimination of
senescent cells. As a by-product of this
process, the p53-induced SASP
establishes an anti-tumor
microenvironment. Thus, this
response serves the dual purposesof wound healing and inhibition
of tumor growth in the surrounding
tissue.
Together, these studies have
uncovered a novel non-cell-
autonomous mechanism of
p53-mediated tumor suppression in
which p53 action in one cell influences
tumor development in another cell.
An obvious implication of these
findings is that in Li-Fraumeni
patients, who are heterozygous for a
p53 mutant allele, or in p53-/- mice,
the observed tumor predisposition
may be fueled in part by lack of intact
non-cell-autonomous p53 tumor
suppressor mechanisms. Continued
analysis of the p53-induced SASP
program and its interplay with the
immune system will further advance
our understanding of p53 tumor
suppression mechanisms. For
example, in which tumor types are
non-cell-autonomous mechanisms
of p53 action most relevant? How
is p53 induced in such settings as
activated HSCs? How do these
non-cell-autonomous p53 functions
affect cancer therapy and can they
be leveraged to enhance tumor
treatment? It is known that
senescence contributes to the
cytotoxicity of anticancer drugs
and that reactivation of endogenous
p53 in p53-deficient murine liver
carcinomas provokes cellular
senescence followed by an innate
immune response that triggers tumor
clearance [12,13]. Thus, a deeper
understanding of the crosstalk
between p53-expressing senescent
cells and other cells of the
microenvironment will ultimately
facilitate the development of novel
chemotherapeutic approaches.References
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Continuing PhagotrophyPlastids evolved after a cell entered a genetically different cell, followed by
integration of the two genomes. Many photosynthetic cells can ingest organic
particles as food, as now demonstrated in an ancestral green alga.Figure 1. Cymbomonas.
Light micrograph of Cymbomonas. The
feeding duct opens to the exterior at the
anterior end of the cell, i.e. the end at which
the four flagella are inserted. The cells do
not always swim with the anterior end
forward. Scale bar represents 5 mm. Photo
courtesy of Eunsoo Kim.John A. Raven
Some eukaryotic photosynthetic
organisms are capable of ingesting
organic particles into their
cells — when the particles are
digested, this combination is termed
mixotrophy. Photosynthetic
eukaryotes originated by ingestion of
pre-existing photosynthetic cells by
(typically) non-photosynthetic cells,
followed by genetic integration.
The first plastids came from a
cyanobacterial endosymbiont, and the
descendants of this ancestor with
vertical inheritance of plastids are the
Archaeplastida, a group which
comprise, in order of evolutionary
divergence, glaucophytes, red algae,
green algae and, derived from the
green algae, ‘higher’ (embryophytic)
plants [1]. The occurrence of
photosynthesis in other eukaryotic
algae such as coccolithophores,
diatoms, dinoflagellates and
euglenoids involved second, and
even third, rounds of endosymbiosis
of eukaryotic photosynthetic algae,
the first round involving members of
the Archaeoplastida, with other
eukaryotic cells [1]. Algae such as
coccolithophores, diatoms, brown
algae and dinoflagellates arose from
endosymbiosis of a red alga, while
euglenoids arose from endosymbiosis
of a green alga [1].
Phagotrophy, or the ingestion of
living or dead particles by cells, occurs
in many groups of photosyntheticeukaryotes, including many algae
that arose by secondary or tertiary
endosymbiosis — even in
embryophytes, which arose from the
primary endosymbiotic event [2,3].
However, phagotrophy by algae has
only been clearly demonstrated in a few
green algae (e.g,. [4]). In a recent issue
of Current Biology, Maruyama and Kim
[5] demonstrate phagotrophy, and,
crucially, some of its structural bases,
in the early-diverging marine flagellate
green alga Cymbomonas (Figure 1). In
the conditions under which the algae
were grown in this study and in which
phagotrophy occurred, it seems that
light availability for photosynthesis
limited growth and possibly triggered
phagotrophy [5], contrasting with
the common requirements for
phagotrophy in nitrogen, phosphorus
and iron acquisition in algae under
natural conditions [2]. To put this in
perspective, it is becoming clear that
algae less than 5 mm in diameter are the
main bacterivores and also the main
autotrophic CO2 assimilators in parts of
the oligotrophic ocean [6,7].
The authors of this new study
showed that the feeding apparatus of
Cymbomonas consists of a duct from
the external environment leading to an
acidic vacuole in which digestion
occurs [5]. The smooth-walled duct,
with a striated root that could be
involved in ingestion of prey, contrasts
with the invaginated membrane of the
food vacuole that might be related to
transfer of the products of digestioninto the cytosol [5]. However, much
remains to be elucidated on the
ecology, cell biology and evolution of
the mixotrophy of Cymbomonas. The
question of the evolution of this
process is significant because of the
evolutionary origin of phagotrophy in
Cymbomonas and its relatives. One
possibility is that phagotrophy in this
lineage is inherited from the ancestor of
the Archaeoplastida, where it was
presumably involved in the primary
plastid endosymbiotic event [5].
Such an origin would require that
phagotrophy was lost in the
glaucophytes — red algae and other
green algae. The other possibility is
that phagotrophy was lost in the
Archaeplastida and that this mode of
feeding was regained by horizontal
gene transfer [5]. Distinguishing
between these alternatives requires
more information on the molecular and
genetic bases of mixotrophy in a range
